- Home
- PMNT vs PMN Comparison
PMNT vs PMN Comparison
Compare PMNT & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMNT
- PMN
- Stock Information
- Founded
- PMNT 1984
- PMN 2004
- Country
- PMNT United Kingdom
- PMN Canada
- Employees
- PMNT N/A
- PMN N/A
- Industry
- PMNT
- PMN Pharmaceuticals and Biotechnology
- Sector
- PMNT
- PMN Health Care
- Exchange
- PMNT NYSE
- PMN Nasdaq
- Market Cap
- PMNT 18.0M
- PMN 18.8M
- IPO Year
- PMNT 2024
- PMN N/A
- Fundamental
- Price
- PMNT $0.98
- PMN $0.61
- Analyst Decision
- PMNT Strong Buy
- PMN Strong Buy
- Analyst Count
- PMNT 1
- PMN 1
- Target Price
- PMNT $6.00
- PMN $6.00
- AVG Volume (30 Days)
- PMNT 27.4K
- PMN 37.4K
- Earning Date
- PMNT 02-14-2025
- PMN 05-13-2025
- Dividend Yield
- PMNT N/A
- PMN N/A
- EPS Growth
- PMNT N/A
- PMN N/A
- EPS
- PMNT N/A
- PMN 0.11
- Revenue
- PMNT $21,307,000.00
- PMN N/A
- Revenue This Year
- PMNT $3.91
- PMN N/A
- Revenue Next Year
- PMNT $29.32
- PMN N/A
- P/E Ratio
- PMNT N/A
- PMN $5.68
- Revenue Growth
- PMNT N/A
- PMN N/A
- 52 Week Low
- PMNT $0.66
- PMN $0.51
- 52 Week High
- PMNT $3.08
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- PMNT N/A
- PMN 48.35
- Support Level
- PMNT N/A
- PMN $0.51
- Resistance Level
- PMNT N/A
- PMN $0.65
- Average True Range (ATR)
- PMNT 0.00
- PMN 0.08
- MACD
- PMNT 0.00
- PMN 0.01
- Stochastic Oscillator
- PMNT 0.00
- PMN 49.96
About PMNT PERFECT MOMENT LTD
Perfect Moment Ltd is a company which is a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear, and activewear. It operates at the intersection of luxury fashion and multi-channel commerce. Although the Company is organized fundamentally as one business segment which is product sales, the Company's revenues are primarily split between three geographic areas which are the U. S., Europe, and the UK.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.